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ABSTRACT
Studies of RNA interference (RNAi) provide evidence
that in addition to the well-characterized cytoplas-
mic mechanisms, nuclear mechanisms also exist.
The mechanism by which the nuclear RNA-induced
silencing complex (RISC) is formed in mammalian
cells, as well as the relationship between the RNA
silencing pathways in nuclear and cytoplasmic com-
partments is still unknown. Here we show by apply-
ing fluorescence correlation and cross-correlation
spectroscopy (FCS/FCCS) in vivo that two distinct
RISC exist: a large ~3MDa complex in the cytoplasm
and a 20-fold smaller complex of ~158kDa in the
nucleus. We further show that nuclear RISC, con-
sisting only of Ago2 and a short RNA, is loaded in
the cytoplasm and imported into the nucleus. The
loaded RISC accumulates in the nucleus depending
on the presence of a target, based on an miRNA-like
interaction with impaired cleavage of the cognate
RNA. Together, these results suggest a new RISC
shuttling mechanism between nucleus and cyto-
plasm ensuring concomitant gene regulation by
small RNAs in both compartments.
INTRODUCTION
Small RNAs have emerged as key regulators of gene
expression, acting in an evolutionary conserved group of
gene-silencing pathways found in eukaryotes (1–3). The
short  19–24 nucleotide (nt) long dsRNA silencing trig-
gers are produced from endogenous or exogenous dsRNA
substrates of various secondary structure (4–7).
Short interfering RNAs (siRNAs) consist of a dsRNA
with a stem of  19nt containing a 50-phosphate and 2nt
overhangs at both 30-ends (5,7). To function as targeting
cofactors, siRNAs are bound by the RISC-loading com-
plex (RLC) consisting of Dicer, TRBP and a member of
the Argonaute (Ago) family (6,8,9). The siRNA-duplexes
are separated into single strands as they assemble into an
Argonaute protein, the core of the RNA-induced-silencing
complex (RISC) (10). The RLC speciﬁcally incorporates
the strand with the lowest thermodynamic stability at
the 50-end of the duplex, termed ‘guide’ strand, into
Argonaute, thereby forming activated RISC whereas the
‘passenger’ strand is removed from the complex and
degraded (11–13). Depending on the extent of complemen-
tarity between the guide RNA and the target mRNA
sequence, in conjunction with the associated Argonaute
family member, RISC can silence gene expression by
endonucleolytic cleavage, translational repression, deade-
nylation, decapping and/or by translocation into P-bodies
(14–16). Furthermore, it has been shown that siRNAs as
well as the nuclear encoded miRNAs, another class of
small dsRNA silencing triggers, depend on Exp5 mediated
nuclear export for cytoplasmic localization and eﬃcient
silencing (17,18).
Nuclear functions for Ago proteins have also been
reported, such as in Schizosaccharomyces pombe, where
Ago is involved in heterochromatin formation to promote
transcriptional gene silencing and in other organisms
including plants, Drosophila and Caenorhabditis elegans
(19–21). Although Ago proteins have been found in cyto-
plasmic and nuclear extracts from mammalian cells, it
could not be excluded experimentally that the nuclear
extracts were contaminated by Ago proteins associated
with the nuclear envelope (22,23). Further indications
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small nuclear RNAs (snRNAs) 7SK and U6 could be
knocked down with siRNAs (23). Also, it has been
shown that exogenously introduced siRNAs complemen-
tary to target sequences within gene promotors (agRNAs,
antigene siRNAs) can either inhibit (transcriptional gene
silencing, TGS) or activate gene transcription in an
Argonaute protein dependent manner in mammalian
cells (24–26). The Argonaute proteins bind to an antisense
transcript or extended 50-untranslated region of the
mRNA that overlaps the gene promoter thereby mediat-
ing the formation of complexes with proteins and
chromosomal DNA necessary for the activation of tran-
scription or TGS in mammalian cells (27,28). However,
endogenous, small dsRNA triggers involved in transcrip-
tion regulation still need to be identiﬁed. In addition, it is
unknown where the nuclear RISC is assembled and how
the cell ensures the nuclear localization of agRNA-loaded
RISC. The knowledge of the localization of its assembly,
e.g. whether nuclear RISC is speciﬁcally loaded inside the
nucleus or originates from cytoplasmic loaded RISC is
important to better understand RNAi-mediated gene reg-
ulation and the interconnection between the cytoplasmic
and nuclear RNAi pathways.
In this study, we used ﬂuorescence correlation spectros-
copy (FCS) and ﬂuorescence cross-correlation spectros-
copy (FCCS) to quantitatively analyse siRNA
incorporation levels in Ago2 proteins and RISC-complex
sizes concomitant in the cytoplasm and nucleus in vivo.
FCS and FCCS are highly sensitive and speciﬁc optical
techniques used for the study of dynamics and interactions
of individual ﬂuorescently labelled molecules in solution
or living cells (for details see Methods section and
Supplementary data) (29–31).
We provide the ﬁrst direct characterization of nuclear
RISC and show that cytoplasmic RNA-induced silencing
complex(cRISC)andnuclearRNA-inducedsilencingcom-
plex (nRISC) are two, clearly distinguishable RISC
complexes in vivo. Analyzing the asymmetric incorporation
of ﬂuorescently labelled siRNAs into nRISC and cRISC,
we found that nRISC originates almost predominantly
from loaded cRISC. Consequently, nRISC and cRISC
are interconnected by the dynamic exchange of RISCs
between the cytoplasm and the nucleus.
MATERIALS AND METHODS
Cellculture
ER293 cells stably transfected with the pERV3 vector
(Stratagene) were cultured at 378C in DMEM (high glu-
cose, Sigma) with 10% FCS (PAA Laboratories GmbH),
2mM glutamine (Gibco) and 0.3mg/ml G418 (50mg/ml,
Gibco).
For the generation of the stable EGFP-Ago2 cell line,
the pEGSH-EGFP-Ago2 vector was linearized with AseI.
ER293 cells were seeded at 4 10
4cells/ml, 24h before
transfection. Transfection was carried out using linearized
DNA and Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s protocols. After 24h cells were trea-
ted with 0.4mg/ml selection antibiotic Hygromycin B
(50mg/ml, Gibco) for 3 weeks. Cells were diluted to
1cell/0.2ml and transferred onto 96-well plates for reclon-
ing. Wells with single colonies were cultured, resulting in
EGFP-Ago2 positive clones that were conﬁrmed via west-
ern blot, immunoﬂuorescence and PCR. The generated
cell line 10G stably expressing EGFP-Ago2 was cultured
at 378C in DMEM (high glucose, Sigma) with 10%
fetal calf serum, 2mM glutamine, 0.3mg/ml G418 and
0.4mg/ml Hygromycin B. All cells were regularly pas-
saged at subconﬂuency and were plated with 1–5 10
4
cells/ml density.
siRNA sequencesand calculation ofthe 5’-end free energy
All siRNA strands were obtained from IBA GmbH.
The RNA oligonucleotides were synthesized with a
50-phosphate and a 30-amino group on a C6-carbon linker
and were labelled with Cy5 succinimidyl ester (Cy5-NHS,
Amersham Biosciences) as described previously (17). The
nucleotides 18–21 were 20-O-methyl modiﬁed to protect the
label from degradation except for silencing assays were the
siRNAs were not modiﬁed. Target-RNA and siRNA
sequences are listed in the Supplementary data.
For siRNA control experiments, we used Silencer
TM
Negative control #2 (NegsiRNA) from Ambion.
The free energies of the ﬁrst 4bp of each siRNA strand
of the duplex at the 50-end was calculated in kcal/mol by
using the nearest-neighbour method and the mfold
algorithm (32,33).
Microinjection
For microinjection, 7–9 10
4 ER293/10G cells were trans-
ferred onto MatTek chambers coated with Fibronectin
(25mg/ml in PBS including CaCl2 and MgCl2, Roche)
24h before microinjection. The micropipette (Femtotip
2, Eppendorf) is loaded with 1.5–4mM labelled siRNAs
(WGA 2.25mg/ml, Biomeda) in 110mM K-gluconate;
18mM NaCl; 10mM HEPES pH 7.4 and 0.6mM
MgSO4. The micromanipulator consists of a FemtoJet
and InjectMan NI2 which is mounted directly on a micro-
scope. Working pressure for injection was between 25 and
80hPa for 0.1s and a holding pressure of 15hPa.
Fluorescence correlation spectroscopy setup
Fluorescence correlation spectroscopy and laser scanning
microscopy (LSM) were carried out on a commercial
system consisting of a LSM510 and a ConfoCor3 (Zeiss,
Jena, Germany). The 488nm line of a Ar-Ion laser and the
633nm line of a HeNe laser were attenuated by an
acousto-optical tunable ﬁlter to 3.5 and 1.05kW/cm
2
and directed via a 488/633 dichroic mirror onto the back
aperture of a Zeiss C-Apochromat 40 , N.A.=1.2, water
immersion objective. Fluorescence emission light was col-
lected by the same objective and split into two spectral
channels by a second dichroic (LP635). To remove any
residual laser light, a 505–610nm bandpass or 655nm
longpass emission ﬁlter, respectively, was employed. The
ﬂuorescence was recorded by avalanche photodiode detec-
tors (APDs) in each channel. For EGFP-Ago2 autocorre-
lation measurements, a mirror substituted the second
dichroic and a 505-nm longpass emission ﬁlter was used
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reduced with a 70-mm pinhole. The ﬂuorescence signals
were software-correlated and evaluated with MATLAB
(Mathworks, Natick, MA, USA) by using weighted
Marquardt non-linear least-square ﬁtting routine.
Laser scanning microscopy was performed using the
APD’s of the ConfoCor3 on the same setup. Cell measure-
ments were performed in air-buﬀer (150mM NaCl,
20mM HEPES pH 7.4, 15mM glucose, 15mg/ml BSA,
10mM trehalose, 5.4mM KCl, 0.85mM MgCl2, 0.7mM
CaCl2) at RT.
Preparation and fractionation ofcell extracts
Fractionated cell extracts were prepared from 10G, 293
and ER293 cells from four conﬂuent T175 chambers
essentially performed as previously described by Robb
et al. (23). Sucrose gradients were exactly performed as
has been described in (34).
Immunoprecipitation
ER293 and 10G cells were lysed with IP buﬀer (0.5% NP-
40, 150mM KCl, 25mM Tris–HCl pH 7.5, 2mM EDTA,
1mM NaF, 0.5mM DTT, protease inhibitors, Roche) and
centrifuged at 10000g for 10min. Extracts were incubated
with anti-GFP (Roche) or anti-p53 for 2h at 48C.
Antibodies were pulled down with protein G Sepharose
4 fast ﬂow beads (GE Healthcare) for 1h at 48C. Beads
were subsequently washed with buﬀer (0.1% NP-40,
300mM KCl, 25mM Tris–HCl pH 7.5, 2mM EDTA,
1mM NaF, 0.5mM DTT, protease inhibitors, Roche)
and with PBS.
Western blotting
For western blot analysis, the cells were lysed with  1.5
loading buﬀer for denaturating polyacrylamide gel
electrophoresis. For immunoblotting, proteins were run
on 7.5–10% PAGE and transferred onto Protran
Nitrocellulose Transfer Membrane (Schleicher &
Schuell). Antibodies: a-EGFP (Abcam ab290, 1:2000),
a-Ago2 clone 11A9 (1:50), a-GAPDH (Abcam 9484,
1:2000), a-Actin (Abcam AC15). Immunoreactive signals
were detected using ECL
TM Western Blotting Detection
Reagents according to the manufacturer’s protocol
(Amersham Biosciences).
qPCR
Total RNA was isolated using the Prep Ease kit (USB,
USA), according to the manufacturer’s instructions, using
DNaseI digestion on column. cDNA was synthesized with
random hexamer primers from 2mg of total RNA using
the First Strand cDNA synthesis kit (Fermentas, Canada),
according to the manufacturer’s protocol. qPCR was per-
formed on a MyiQ cycler (BioRad, USA) using the Mesa
GreenqPCRmastermix(Eurogenetec,Belgium)withprim-
ers at 100nM ﬁnal concentration and a two-step PCR pro-
tocol (5min initial denaturation at 958C, 40 cycles with 10s
at 958C and 1min elongation at 608C). The primers were
(forward, reverse): GAPDH, 50 TGGTATCGTGGA
AGGACTCATGAC, 50 ATGCCAGTGAGCTTCCCGT
TCAGC; 7SK, 50 CCTGCTAGAACCTCCAAACAAG,
50 GCCTCATTTGGATGTGTCTG. Data were evaluated
using the Ct method.
RESULTS
To investigate RISC by FCS/FCCS in vivo, we created a
293 based cell line, in which hAgo2 is tagged with the
enhanced green ﬂuorescent protein (EGFP). For this
study, hAgo2 was chosen, because it has been demon-
strated that it is involved in nuclear RNAi, is associated
with siRNAs and miRNAs, endonucleolytically active and
that tagging hAgo2 on the N-terminus with EGFP had no
eﬀect on hAgo2 RNAi activity and sub-cellular localiza-
tion (35,36). The characterization of the newly generated
cell line 10G revealed that the EGFP-Ago2 protein
reproduces the enzymatic activity, protein/RNA interac-
tions, sub-cellular localization, expression level and
function of endogenous hAgo2 protein (Supplementary
Figure S1A–D).
Nuclear RISC differs from cytoplasmic RISC
Although the human RISC complex has been intensely
studied, the protein composition is still not entirely
clear, with reported molecular weights from  160kDa
to  2MDa (37,38). The huge deviation in molecular
mass might depend on extract generation or on the experi-
mental procedure for their estimation. To avoid prepara-
tion artefacts, we measured hAgo2 containing RISC
complexes in thermal equilibrium in vivo in 10G cells
and determined the molecular mass of the individual
RISC in diﬀerent cellular compartments by FCS (for
details see Supplementary materials). The autocorrelation
curves of EGFP in 293cells resulted in almost identical
diﬀusion times in the cytoplasm and the nucleus of
 EGFP(cytopl)=(354 13)msand EGFP(nucl)=(368 8)ms,
corresponding to a diﬀusion coeﬃcient of DEGFP(cytopl)=
(25.5 0.9)mm
2/s and DEGFP(nucl)= (24.5 0.5)mm
2/s,
indicating that the viscosity and therefore the motility is
approximately the same in both compartments
(Figure 1A) (39). In contrast, measurements in 10G cells
displayed a signiﬁcant diﬀerence in diﬀusion time for
EGFP-Ago2 between the cytoplasm ( EGFP-Ago2(cytopl)=
(1678 58)ms, DEGFP-Ago2(cytopl)=(5.4 0.2)mm
2/s) and
the nucleus ( EGFP-Ago2(nucl)=(657 22)ms, DEGFP-
Ago2(nucl)=(13.7 0.5)mm
2/s). With respect to EGFP,
these diﬀusion times correspond to a molecular weight
of (3.0 0.6)MDa for cRISC and (158 26)kDa for
nRISC. While the obtained molecular weight for cRISC
is in the range of a previously isolated RISC of about
2MDa (37), the molecular weight of nRISC resembles
almost the distinct EGFP-Ago2 alone. It should be
noted that the molecular mass for cRISC could be over-
estimated due to a higher eﬀective viscosity a larger mole-
cule experiences in a crowded environment. Yet, due to
the  20-fold diﬀerence in molecular mass, we conclude
that cRISC represents a diﬀerent complex compared to
nRISC. Further analyses of the measurements indicate
that within the accuracy of the FCS technique no distinct
Nucleic Acids Research, 2008, Vol. 36, No. 20 6441EGFP-Ago2 is present in the cytoplasm (Supplementary
data).
Western blot analysis of nuclear and cytoplasmic 10G-
extracts with an EGFP-speciﬁc antibody yielded a single
speciﬁc band for EGFP-Ago2 at 130kDa, demonstrating
the absence of contaminating EGFP-Ago2 fragments in
the nucleus (Figure 1B). Therefore, nRISC is not formed
by a truncated version of EGFP-Ago2. To corroborate the
FCS data, sucrose gradients with nuclear and cytoplasmic
extracts from 293 cells were performed. The cytoplasmic
extracts displayed the aforementioned hAgo2 containing
complexes I–III with a large portion of complexes being
bigger than 350kDa. The large complexes II–III were
missing in nuclear extracts (Figure 1C). The same result
was obtained for hAgo1 (data not shown). The discrep-
ancy between the obtained molecular weights and the pro-
portions of diﬀerent RISC in sucrose density gradients
and FCS measurements lie within the diﬀerent experimen-
tal techniques. Whereas FCS is a real-time acquisition
technique in vivo, the gradient extract preparation includes
a centrifugation step which excludes the analysis of high
molecular weight complexes. Furthermore, the sucrose
gradients are performed over a period of 20h which
might lead to the disassembly of the majority of RISC
complexes. However, the results obtained by FCS are sup-
ported by sucrose gradients illustrating the absence of
higher molecular weight complexes in the nucleus.
To characterize the sub-cellular distribution of hAgo2
containing complexes, we quantiﬁed the amount of
EGFP-Ago2 in the nucleus and the cytoplasm by FCS
and imaging. EGFP-Ago2 preferentially localized to the
cytoplasm with a cytoplasmic to nuclear ratio of
(4.2 0.5):1 determined by FCS and (4.7 0.5):1 deter-
mined by imaging (for details see Supplementary materi-
als). The higher value for imaging might be caused by the
accumulation of EGFP-Ago2 into P-bodies, which are not
accessible with FCS.
We could directly characterize RISC sizes in the nucleus
in thermal equilibrium by FCS in vivo without preparation
artefacts and contaminations by cRISC. Our data demon-
strate that cytoplasmic EGFP-Ago2 is part of a large
complex and diﬀers from nRISC which most probably
represents the discrete EGFP-Ago2 protein. We obtained
a cytoplasmic to nuclear EGFP-Ago2 concentration of
 4–5, indicating that hAgo2 is not as underrepresented
in the nucleus as estimated by previous imaging studies.
This might result from the high expression levels in tran-
sient systems in previous reports, compared to the almost
endogenous expression levels of EGFP-Ago2 in 10G
cells (35,36).
Asymmetric guide strand incorporation into
nuclear and cytoplasmic RISC
The incorporation of siRNAs into nRISC and the eﬀects
of target interactions on the distribution of activated
RISC in the cytoplasm and the nucleus in mammalian
cells are largely unknown. To assess siRNA incorporation
levels and asymmetric loading of the guide strand into
RISC by FCCS in vivo (for details see Supplementary
materials), we covalently labelled siRNAs on the 30-end
of the guide or passenger strand with Cy5 (illustrated in
Figure 2C and D top) and delivered them directly into
10G cells via microinjection to avoid siRNA segregation
within endocytic compartments. This resulted in silencing
active and homogeneous localized cytoplasmic siRNAs
required for FCCS (17). The siRNA siTK3 targets the
mRNA of Renilla luciferase encoded on the plasmid
pRL-TK. The 50-end hybridization energy of siTK3 was
calculated as described (12) to deﬁne the guide and pas-
senger strand of the siTK3 duplex (Figure 2A). The siTK3
siRNA was used as it displayed high levels of Renilla
luciferase silencing, demonstrating the incorporation of
the guide strand into endogenous RISC (Figure 2B).
Microinjection of the passenger strand labelled siTK3
resulted in cross-correlation amplitudes between 0% and
5% in the cytoplasm and nucleus up to 12h, indicating the
exclusion of the passenger strand from RISC (Figure 2C).
On the contrary, guide strand labelled siTK3 lead to sig-
niﬁcant cross-correlation amplitudes in the nucleus and
the cytoplasm gradually increasing for up to 6h with a
slight decline thereafter (Figure 2D). As the relative ampli-
tude of the cross-correlation function is directly propor-
tional to the concentration of double labelled species, this
result demonstrates the speciﬁc incorporation of the guide
strand into nuclear and cytoplasmic RISC whereas the
passenger strand is excluded during the loading process.
The speciﬁc incorporation of the guide strand could be
Figure 1. Nuclear RISC diﬀers from cytoplasmic RISC. (A) Normal-
ized FCS curves of EGFP-Ago2 as measured in the nucleus (dashed
black line) and cytoplasm (black line) of 10G cells. The graph exhibits
the autocorrelation functions G( ) at lag time   (for more details on
FCS and the autocorrelation function see Supplementary materials).
Curves are the average of at least 10 measurements. As control, FCS
curves were recorded for EGFP alone in ER293 cells (nucleus: green
dashed line, cytoplasm: green line). (B) Western blot of 10G nuclear
and cytoplasmic extracts for EGFP-Ago2. To show the purity of the
nuclear and cytoplasmic fractions, western blot analysis was performed
with a-Cyclin T1 and a-GAPDH antibody. (C) HEK 293 cytoplasmic
and nuclear extracts were separated by sucrose density centrifugation
under conditions that allow the separation of diﬀerent hAgo2 contain-
ing mRNPs that were analysed by western blot with speciﬁc a-hAgo2
antibody.
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0.5kcal/mol (siGL2) (data not shown). Interestingly, the
incorporation levels in the nucleus and the cytoplasm syn-
chronistically increased and declined, in the nucleus
however to a lower level, reaching saturation after 6h
(Figure 2D, bottom panel). Similar results were obtained
with other siRNAs: siTK2 (Supplementary Figure S3),
siRNA targeting Fireﬂy luciferase (siGL2) and
siGAPDH (data not shown). Guide strand labelled
siRNAs could be examined for longer time periods com-
pared to passenger strand labelled siRNAs, due to the loss
of the Cy5 signal in passenger strand containing cells. This
most probably results from a stabilization of the guide
strand caused by the interaction with RISC whereas the
passenger strand gets degraded. Control experiments with
EGFP supplemented with guide strand labelled siTK3
exhibited no cross-correlation amplitude, whereas a
double labelled control resulted in 80% cross-correlation
amplitude in vitro (Supplementary Figure S4A and B).
For the ﬁrst time, we could monitor the asymmetry
dependent incorporation into nRISC and show that
nuclear levels of guide strand incorporation correlate
with cytoplasmic incorporation levels in time in vivo.
The speciﬁc guide strand incorporation into nRISC pro-
vides additional evidence for the speciﬁc loading and func-
tion of nRISC.
nRISC loading levels are affected by target RNA
interactions
The snRNA 7SK can be speciﬁcally silenced with an
siRNA (23). In the previous section, we showed that
siRNAs can be detected in nRISC independently of
endogenous targets. To elucidate the eﬀect of a nuclear
target, we microinjected guide or passenger strand labelled
si7SK1 (23) targeting 7SK snRNA. In conformity with
our previous experiments, the asymmetric incorporation
of the guide strand into cytoplasmic and nuclear RISC
was observed, whereas the passenger strand was excluded
from both complexes (Figure 3A). Interestingly, the
si7SK1 loaded RISC accumulated much stronger in the
nucleus between 1h and 6h after microinjection compared
to all siRNAs tested (Figure 3A and B). Knock down of
7SK snRNA with two unrelated siRNAs 48h before
microinjection resulted in a decrease in cross-correlation
amplitude that resembles the values of siTK3 (Figure 3C)
and other siRNAs (data not shown) indicating a target
dependent si7SK1-loaded RISC accumulation in the
nucleus. A control transfection with NegsiRNA did
not aﬀect si7SK1-RISC accumulation in the nucleus
(Figure 3C). Interestingly, another siRNA targeting
7SK snRNA (si7SK2) did not result in increased cross-
correlation amplitudes in the nucleus, suggesting that the
presence of a nuclear target per se is not suﬃcient for
target dependent nRISC accumulation (Figure 3B and
C). The target sites of the two siRNAs within 7SK
snRNA structure are diﬀerent (40), si7SK1 hybridizes
with its seed sequence in a single stranded loop where
the cleavage site is masked in a dsRNA stretch, whereas
si7SK2 binds to a relatively unstructured part of 7SK
snRNA (Figure 3D). By analyzing the silencing eﬃciency
of si7SK1 and 2, we found that si7SK2 silences 7SK
snRNA down to 20% whereas si7SK1 resulted in  60%
of relative 7SK levels (Figure 3E). It has been shown that
dsRNA structures in close proximity to the cleavage site
from the 30-end inhibit cleavage (41). Furthermore, a
target site in a small loop structure leads to steric problems
resulting in reduced cleavage rates. These results are con-
sistent with our silencing data (Figure 3E). To test the idea
that binding of RISC to its target RNA without endonu-
cleolytic cleavage leads to accumulation of loaded RISC in
the nucleus, we compared an siRNA forming a central
bulge (si7SK3-bulge) with the target site in an unstruc-
tured part of the 7SK snRNA to its perfect matching
siRNA (si7SK3). The silencing eﬃciencies of the two
siRNAs were analysed by qRT-PCR. Si7SK3 eﬃciently
Figure 2. Asymmetric guide strand incorporation into nuclear and
cytoplasmic RISC. (A) Illustration of the sequence and free energies
of the siRNA siTk3. To follow the incorporation of the individual
strands, the duplexes were either labelled on the 30-end of the guide
or passenger strand. (B) ER293 cells were transfected with the indicated
amounts of siTK3 or NegsiRNA together with the ﬁxed concentration
of the pGL2-control and pRL-TK reporter plasmids. After 48h, the
ratios of target to control luciferase concentrations were normalized
to the NegsiRNA control indicated in dark grey; siTK3 is indicated
in grey. The plotted data were averaged from three diﬀerent
experiments SD. (C) Normalized cross-correlation curves of EGFP-
Ago2 and the labelled passenger strand of siTK3 in the cytoplasm for
diﬀerent incubation times after microinjection in 10G cells in vivo (top).
Curves are the average of at least 10 measurements. The resulting cross-
correlation amplitudes in the cytoplasm (ﬁlled boxes) and nucleus
(open circles) are displayed in the bottom graph. (D) Normalized
cross-correlation curves for the labelled guide strand of siTK3 in
the cytoplasm (top). The bottom graph depicts the resulting cross-
correlation for diﬀerent incubation times in the cytoplasm (ﬁlled
boxes) and nucleus (open circles) as indicated by the cartoon. Data
are represented as mean SEM.
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position 9–11 completely impaired silencing (si7SK3-
bulge; Figure 3E). Evaluation of the incorporation levels
in the cytoplasm and the nucleus also displayed the accu-
mulation of silencing impaired si7SK3-bulge loaded RISC
in the nucleus, whereas the perfect match siRNA resulted
in a 2-fold lower cross-correlation amplitude inside the
nucleus. The cytoplasmic incorporation levels were not
aﬀected (Figure 3F). Additionally, the inhibition of
target RNA cleavage by the si7SK3-bulge resulted in
higher incorporation levels in the nucleus compared to
the si7SK1 for incubation times longer than 6h (Supple-
mentary Figure S5A). The si7SK1 nuclear cross-correla-
tion amplitude decreased after 6h, a result of reduced
levels of 7SK RNA due to the marginal silencing activity
of si7SK1 during the time course compared to si7SK3-
bulge with impaired cleavage. The analysis of the cytoplas-
mic to nuclear ratio of EGFP-Ago2 concentration did not
show signiﬁcant changes that can be related to the accu-
mulation of EGFP-Ago2 loaded with si7SK3 and si7SK3-
bulge siRNA in the nucleus (Supplementary Figure S5B).
Therefore, we could show that EGFP-Ago2 levels remain
stable, leading only to the accumulation of the particularly
loaded RISCs in the nucleus.
We also analysed the sub-cellular localization of si7SK1
in living cells by quantifying ﬂuorescence intensity.
We could not detect increased levels of si7SK1 RNA
labelled on either strands in the nucleus of 10G or
ER293 cells compared to other siRNAs (Supplementary
Figure S5C). The analysis of siRNA sub-cellular localiza-
tion by imaging does not correlate with target RNA loca-
lization, since the majority of siRNAs is not bound by the
RLC/RISC and therefore the sub-cellular localization is
mainly aﬀected by Exp5 mediated export illustrated by
siRNA incorporation levels of <35%.
Taken together, our data show that nRISC loaded with
a speciﬁc guide RNA can accumulate in a target and dura-
tion of the interaction dependent fashion, indicating that
this process is dynamic and does not result from a stable
fraction of RISC in the nucleus. The nuclear hAgo2 pro-
tein concentration seems to be highly regulated, since a
2-fold increase of speciﬁcally loaded nRISC did not
change the overall cytoplasmic to nuclear concentration
ratio of EGFP-Ago2.
Cleavage impaired RISC-target interactions
mediate RISC accumulation in thenucleus
To directly investigate the eﬀect of RISC-target-RNA
interactions in the nucleus and cytoplasm by FCCS, we
microinjected a 50nt long RNA into 10G cells that is
labelled with Cy5 on the 50-end, contains the siTK3
target site and is modiﬁed with 20-O-methyl on each end
Figure 3. nRISC loading levels are aﬀected by target RNA interactions. (A) Cross-correlation amplitude in the cytoplasm (ﬁlled boxes) and nucleus
(open circles) of the nuclear targeting siRNA 7SK1 for diﬀerent incubation times. Values were obtained by either labelling the guide strand (blue) or
passenger strand (grey) and measuring in at least 10 cells. The sequence and free energies of the siRNA is illustrated. (B) Cross-correlation
experiments of the nuclear targeting siRNA 7SK1 as shown in (A), graphed as ratio of the cross correlation in the nucleus over the cross-correlation
in the cytoplasm. In addition, the ratios of other tested siRNAs are plotted. (C) Target speciﬁcity of the nuclear accumulation of the siRNA 7SK1.
Plotted are the cross-correlation ratios nucleus to cytoplasm after 3h of incubation for 7SK1 and for 7SK1 after the transfection (48h) of a
NegsiRNA, the siRNA 7SK2 and 7SK3. Additionally, the ratios for si7SK2 and siTK3 are depicted for comparison. (D) Schematic overview of
the target sites of the used 7SK siRNAs used to analyse the inﬂuence of target interaction. (E) Quantitative PCR (qPCR) analysis of 7SK snRNA
knockdown with diﬀerent indicated siRNA duplexes. (F) Cross-correlation amplitude in the cytoplasm (ﬁlled bars) and nucleus (open bars) after 3h
of incubation for the siRNAs 7SK1, 7SK3-bulge, 7SK3, 7SK2 and for comparison GAPDH. Mean values SEM.
6444 Nucleic Acids Research, 2008, Vol. 36, No. 20to protect the target-RNA molecule against cellular
RNases. The interaction of the EGFP-labelled RISC con-
taining an unlabelled siRNA with the target-RNA can
then be visualized by increased cross-correlation ampli-
tudes (Figure 4A). The target-RNA localized to the cyto-
plasm and displayed a slight accumulation of ﬂuorescence
signal in the nucleus and even stronger in nucleolar struc-
tures (Figure 4B). FCCS measurements in non-transfected
and NegsiRNA transfected 10G cells after 1 and 3h of
target-RNA delivery showed no interaction of RISC
with the target-RNA illustrating assay speciﬁcity and the
absence of miRNA target sites within the target-RNA
(Figure 4C). Longer incubation times were not tested as
already 30% of target-RNA was degraded after 3h in S20
extracts as determined by PAGE (data not shown).
Despite that, transfection of perfectly matching siTK3
resulted in very low levels of EGFP-Ago2-target-RNA
interactions (Figure 5C). In contrast, transfection of
siTK3-B2 which forms a central bulge with the siTK3-
target site yielded high levels of RISC-bound target-
RNA in the cytoplasm. In the nucleus however, levels
were 3-fold lower after 1h with an increase after 2 and
3h almost reaching cytoplasmic interaction levels
(Figure 4C). The complete inactivation of the siTK3-B2
cleavage activity was veriﬁed by a dual luciferase assay
(Figure 4D).
These results demonstrate (i) the localization of func-
tional guide strand loaded RISC to the nucleus, (ii) the
short interaction time of RISC loaded with a perfectly
matching guide strand with the target-RNA and that
(iii) bulges in the centre of the guide-target-RNA hybridi-
zations increase the lifetime of RISC-target-RNA interac-
tion, resulting in the accumulation of the complex in the
nucleus over time. This is in strong agreement with our
previous results showing the accumulation of speciﬁcally
loaded RISC in a target- and duration of the interaction
dependent fashion. Therefore, the target-dependent accu-
mulation of nRISC is caused by the stable interaction of
RISC with its target and not by the nuclear localization of
Figure 4. Cleavage impaired RISC-target interactions mediate RISC
accumulation in the nucleus. (A) An outline of the experiment is illu-
strated. EGFP-Ago2 serves as a ﬂuorescent label for RISC that can
interact with the Cy5 labelled target-RNA. The interaction with the
target-RNA is determined by FCCS in vivo.( B) LSM images of a
target-RNA microinjected 10G cell (green: EGFP-Ago2, red: target-
RNA, right panel: overlay). Scale bars indicate 10mm. (C) Cross-
correlation measurements were performed 1 or 3h after microinjection.
Data are represented as mean SEM, ﬁlled bars indicate measurements
in the cytoplasm, open bars in the nucleus. (D) ER293 cells were
transfected with the indicated amounts of NegsiRNA, siTK3 and
siTK3-B2 together with the ﬁxed concentration of the pGL2-Control
and pRL-TK reporter plasmids. After 48h, the ratios of target to
control luciferase concentrations were normalized to the NegsiRNA
control (black); siTK3-B2 (grey) and siTK3 (white). The plotted data
were averaged from three diﬀerent experiments SD.
Figure 5. Nuclear activated RISC originates from the cytoplasm. The
incorporation of the guide strand of 7SK1 into RISC was measured for
a cytoplasmic microinjection, a cytoplasmic injection together with
wheat germ agglutinin (WGA) to inhibit active transport through the
nuclear pore and a nuclear injection of 7SK1 and WGA. LSM images
(red: Cy5, green: EGFP, yellow: overlay) and cross-correlation mea-
surement were taken 3h after incubation. Scale bars indicated 10mm,
data are represented as mean SEM; ﬁlled bars indicate measurement
in the cytoplasm, open bars in the nucleus.
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ciﬁcally loaded nRISC.
Nuclear activated RISC originates fromthe cytoplasm
The fact that we could detect a target dependent accumu-
lation of nRISC raises the question of the origination of
nRISC. Two mechanisms are possible: First, RISC is
loaded both inside the nucleus and the cytoplasm or
second, RISC is loaded in the cytoplasm and can than
be imported into the nucleus to regulate gene expres-
sion/function. The ﬁrst hypothesis is less likely for several
reasons. The nRISC that was characterized by FCS in vivo
displayed a molecular mass of  158kDa which is too
small for the RLC (containing EGFP-Ago2, TRBP and
Dicer which should result in a complex of approximately
380kDa). In addition, siRNAs are too short to contain
localization signals, therefore the RLC is incapable to
locate the appropriate cellular compartment for individual
silencing triggers until RISC interacts with its target RNA.
And last, miRNAs and siRNAs depend on their cytoplas-
mic localization, mediated by Exp5, for eﬀective silencing
to occur (17,18,42). To elucidate the cytoplasmic origin of
nRISC, we microinjected si7SK1 into the cytoplasm of
10G cells and allowed for exchange between nucleus and
cytoplasm. This resulted in a preferential cytoplasmic
localization of the siRNAs with 24% of EGFP-Ago2
loading levels in the cytoplasm with the corresponding
nuclear levels of 21% after 3h (Figure 5). In the second
experiment, we microinjected siRNAs into the cytoplasm
together with wheat germ agglutinin (WGA), an inhibitor
of nuclear pore-mediated active transport. The sub-
cellular localization of the siRNAs was still preferentially
in the cytoplasm, but due to their small size could still be
detected in the nucleus (Figure 5). The cytoplasmic incor-
poration levels were unaﬀected compared to WGA-free
microinjected cells showing that WGA did not interfere
with the RISC loading process. The nuclear incorporation
level decreased 3-fold down to 7%, indicating that most
of nRISC is originating from the cytoplasm. The same
decrease in EGFP-Ago2 nuclear incorporation levels
were detected by nuclear microinjection of si7SK1
together with WGA. The drop of loaded EGFP-Ago2
with si7SK1 in the cytoplasm results from reduced
siRNA levels in the cytoplasm mediated by WGA. The
preferential delivery of siRNAs via microinjection into
the nucleus could be detected by the higher ﬂuorescence
intensity in the nucleus in comparison with the cytoplasm
(Figure 5). The same results were obtained for si7SK3-
bulge (Supplementary Figure S6). The inhibitory function
of injected WGA on import and export processes was
veriﬁed with the stress kinase Mk2 tagged with EGFP.
Upon stress this predominantly nuclear protein shuttles
into the cytoplasm (43). We could show that EGFP-
MK2 shuttles into the cytoplasm after treatments with
Anisomycin for 3h that could be stopped with the addi-
tion of Leptomycin B which is an inhibitor of the exporter
of MK2 (Supplementary Figure S7A, upper panel and
S7B). The microinjection with WGA inhibited the
export of EGFP-MK2 very eﬃciently (Supplementary
Figure S7A, bottom panel and S7B). Treatment with
cycloheximide did not change incorporation levels of
EGFP-Ago2 in the nucleus, thereby excluding that the
accumulation of speciﬁcally loaded RISC in the nucleus
results from de novo synthesis of EGFP-Ago2 which is
transported in the nucleus and subsequently loaded
(Supplementary Figure S8).
Our results show that RISC is loaded in the cytoplasm
and is imported into the nucleus. Therefore, the RLC is
strictly localized in the cytoplasm. The accumulation of
the si7SK1 and si7SK3-bulge siRNA indicates a dynamic
exchange of RISC between the nucleus and the cytoplasm.
Furthermore, the interaction with the target RNA seems
to interfere with the export of RISC leading to the accu-
mulation of this particularly loaded RISC in the nucleus.
RISC shuttling between the cytoplasm and the nucleus
represents a mechanism to access targets in both cellular
compartments.
DISCUSSION
To summarize our ﬁndings, we propose the following
model for human RISC loading and shuttling between
the cytoplasm and the nucleus (Figure 6). (i) We could
show for the ﬁrst time that the RLC is localized and inter-
acts with siRNAs/miRNAs exclusively in the cytoplasm.
This is supported by Exp5 mediated nuclear export of
small dsRNAs that actively reduces the concentration of
silencing triggers in the nucleus and hence would lower the
loading eﬃciency of nRISC (17,18). Consequently,
miRNAs as well as siRNAs depend on the cytoplasmic
localization for eﬃcient silencing activity. The RLC
senses the asymmetry of the duplex and speciﬁcally incor-
porates the guide strand into hAgo2, thereby forming
cRISC. This process seems to be regulated, as FCCS mea-
surements immediately after microinjection yielded low
Figure 6. Model for human RISC loading and shuttling between the
cytoplasm and the nucleus. (i) Asymmetric guide-strand incorporation
is localized to the cytoplasm only, (ii) Guide-strand mediated target
recognition in the cytoplasm, (iii) A perfect match results in RISC
mediated target degradation, (iv) A fraction of cytoplasmic loaded
RISC is imported into the nucleus to ensure cell wide target regulation.
Cytoplasmic co-factors dissociate from hAgo2 protein, thereby forming
nRISC, (v) Guide-strand mediated target recognition in the nucleus.
A perfect RISC-target interaction leads to free RISC which can be
exported into the cytoplasm, and (vi) whereas a miRNA-like interac-
tion leads to the accumulation of RISC in the nucleus resulting in
eﬃcient regulation in the nucleus.
6446 Nucleic Acids Research, 2008, Vol. 36, No. 20levels of loaded RISC. Most of the guide strands were
incorporated within the ﬁrst 3–12h, followed by a decline
for longer incubation times. (ii) We proved that the major-
ity of activated cRISC remains in the cytoplasm as a com-
plex of  3MDa to regulate gene expression of mRNAs.
(iii) In case of perfectly priming guide strands to target
RNAs, cRISC catalyses RNA degradation. For
miRNAs, cRISC remains bound to the mRNA to
regulate its expression and/or translocation to P-bodies.
(iv) Our results indicate a partial translocation of acti-
vated cRISC into the nucleoplasm thereby forming
nRISC of  158kDa, most likely composed of only
hAgo2. We were not able to monitor whether EGFP-
Ago2 loses the RLC components Dicer, TRBP and
other factors before or during the translocation, but
RLC disassembly after guide strand incorporation is sup-
ported by previous reports in vitro (44,45). The partial
translocation of loaded hAgo2 is in agreement with the
ﬁndings by Robb et al. (23) who observed cleavage activity
in cytoplasmic and nuclear extracts. (v) In contrast to
Robb et al., we were able to directly compare guide
strand incorporation levels with hAgo2 concentration
and intracellular localization as well as the interaction
dynamics of RISC with its target RNA. We therefore
could demonstrate that perfectly priming guide-target
RNA hybridizations lead to target RNA cleavage, imme-
diately causing RISC-target RNA-complex disassembly,
resulting in free nRISC which is in agreement with the
kinetic analysis of minimal RISC in vitro (41). (vi) On
the contrary, cleavage impaired nRISC, e.g. caused by
dsRNA regions or bulges, results in the accumulation of
this particularly loaded RISC in the nucleus, facilitated by
its prolonged interaction with the target RNA. Due to the
artiﬁcially induced target-RNA-RISC accumulation, we
can exclude that the target dependent accumulation of
nRISC is facilitated by the strict nuclear localization of
7SK snRNA and therefore results from the stable interac-
tion of RISC with its target. Since we never detected a
concentration increase of nRISC, we reason that a stable
equilibrium between n- and cRISC exists that is shifted for
a particularly loaded nRISC depending on the target
interaction.
Taken together, our results propose a RISC exchange/
shuttling mechanism between the cytoplasm and the
nucleus. Due to the absence of nuclear localization signals
in siRNAs and miRNAs, this shuttling mechanism ensures
the accessibility of activated RISC to target containing
cellular compartments. The shuttling of hAgo2 into the
nucleus also explains why agRNAs can function in the
nucleus. Due to the identical localization patterns of
hAgo1 and hAgo2 (23), we propose that nuclear hAgo1
also originates from the cytoplasm to mediate transcrip-
tion activation or TGS. In agreement with our model, the
ﬁndings that also let-7 miRNA is incorporated into
nuclear hAgo2 and that computational approaches
showed that many identiﬁed miRNAs have substantial
complementarity to sequences within gene promotors pro-
vide further evidence for the existence of an endogenous
RNA-mediated transcription regulation machinery origi-
nating from cytoplasmic activated Argonaute proteins
(23,28).
In a previous report, Berezhna and colleagues observed
by confocal imaging that siRNAs targeting 7SK and U6
snRNAs localize into the nucleus as duplexes whereas an
siRNA targeting cytoplasmic hepatitis C virus replicon
RNA dissociates into the cytoplasmic localized guide
strand and a degraded passenger strand after transfection.
From this Berezhna et al. (46) concluded the existence of a
mechanism by which the RISC-loading machinery orches-
trates a target-determined localization of siRNAs and pro-
vide evidence for RISC-loading in the nucleus. In contrast
to their ﬁndings, we showed that the analysis of siRNA
sub-cellular localization by imaging is mainly aﬀected by
Exp5 mediated export, since the majority of siRNAs is not
bound by the RLC/RISC thereby excluding a target-deter-
mined localization. Further arguing against the target-
determined siRNA localization hypothesis is the stable
hAgo2 concentration that we observed in the nucleus inde-
pendent of the incorporated guide strand and our direct
evidence for exclusive cytoplasmic RISC-loading. In addi-
tion, RISC has been shown to identify its target and
deﬁnes the silencing mode after the removal of the passen-
ger strand depending on the complementarity to its target,
supporting our observations (47). The localization of the
complete siRNA duplex in the nucleus, as observed by
Berezhna et al., would imply that the RLC is able to
sense whether the bound siRNA duplex has a nuclear or
cytoplasmic target. However, siRNAs are only bound
brieﬂy to the RLC in form of a duplex as we could not
detect signiﬁcant levels of incorporated passenger strand
in neither RISCs. Findings by Robb et al. (23) also
showed the target independent localization of guide
RNAs in nuclear extracts. In addition, we showed that
nRISC consists of a distinct hAgo2 protein that cannot
bind dsRNA (48).
Underlining our model, it was shown that miR-138 is
restricted to distinct cell types, whereas its precursor pre-
miR-138-2 is ubiquitously expressed and cytoplasmically
localized, thus showing the regulation on the post-
transcriptional level in the cytoplasm (49). In combination
with our results that the RLC is restricted to the cyto-
plasm, this post-transcriptional control of miRNA
maturation in the cytoplasm applies to the regulation of
guide strand incorporation into c- and nRISC.
As the interaction of nRISC with its target seems to
prevent its export, this mechanism might prevent speciﬁc
RNA transcripts from entering the cytoplasm and asso-
ciating with the translation machinery. Further studies on
the eﬀect of nRISC-target RNA interactions and the
sequencing of miRNAs or other classes of small RNAs
in nRISC are needed to unravel the biological role of
the nuclear RNAi machinery.
The advantage of our newly established experimental
platform is the detailed real-time monitoring of the incor-
poration process into RISC in vivo. It represents a unique
tool to address so far inaccessible questions from a new
perspective. Our FCCS assay is superior in studying the
impact of siRNA sequence and structure on RISC loading
and strand asymmetry compared to standard silencing
readouts that are normally used in high-throughput
assays. Therefore, our technique can contribute to the
development of improved siRNA duplexes with diﬀerent
Nucleic Acids Research, 2008, Vol. 36, No. 20 6447functions suitable for the application as therapeutic
agents. It can be used for screening chemicals that aﬀect
the activity of the RLC or the interaction of RISC with the
target RNA which was not possible in vivo until now.
Furthermore, the possibility of studying RISC-target
interactions can lead to the engineering of RNAs that
can inhibit speciﬁc RNA functions, structures or aﬀect
for example alternative splicing and other RNA depen-
dent mechanism.
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